Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aterian, Inc. | 49,906 | reported | 30 Sept 2021 | tx 9+58,355−28,325 |
| PLUS THERAPEUTICS, INC. | 40,122 | reported | 18 Feb 2025 | tx 14+244,305 |
| PROS Holdings, Inc. | 0 | reported | 09 Dec 2025 | tx 66+249,360−284,360 |
| ROO GROUP INC | 0 | reported | 28 Dec 2012 | tx 3+50,120−50,120 |
| Diligent Board Member Services, Inc. | 0 | reported | 14 Apr 2016 | tx 10+436,828−436,828 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Dec 2025 | OTHER | PROS Holdings, Inc. | 125,170 | 23.25 USD | |
| 09 Dec 2025 | OTHER | PROS Holdings, Inc. | 11,262 | 0.00 USD | deriv |
| 08 May 2025 | EXERCISE | PROS Holdings, Inc. | 6,125 | 16.87 USD | |
| 08 May 2025 | GRANT_AWARD | PROS Holdings, Inc. | 11,262 | 0.00 USD | deriv |
| 08 May 2025 | EXERCISE | PROS Holdings, Inc. | 6,125 | 0.00 USD | deriv |
| 18 Feb 2025 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 40,122 | 0.00 USD | deriv |
| 11 Sept 2024 | PURCHASE | PLUS THERAPEUTICS, INC. | 12,500 | 1.35 USD | |
| 11 Sept 2024 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 3,650 | 0.00 USD | deriv |
| 11 May 2024 | EXERCISE | PROS Holdings, Inc. | 7,205 | 30.63 USD | |
| 15 May 2024 | GRANT_AWARD | PROS Holdings, Inc. | 6,125 | 0.00 USD | deriv |
| 11 May 2024 | EXERCISE | PROS Holdings, Inc. | 7,205 | 0.00 USD | deriv |
| 08 May 2024 | PURCHASE | PLUS THERAPEUTICS, INC. | 12,255 | 2.04 USD | |
| 08 May 2024 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 24,510 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 2,250 | 0.00 USD | deriv |
| 11 Sept 2023 | PURCHASE | PLUS THERAPEUTICS, INC. | 20,000 | 1.70 USD | first after silence |
| 12 May 2023 | SALE | PROS Holdings, Inc. | 2,383 | 24.61 USD | |
| 11 May 2023 | EXERCISE | PROS Holdings, Inc. | 6,809 | 24.98 USD | |
| 11 May 2023 | EXERCISE | PROS Holdings, Inc. | 6,809 | 0.00 USD | deriv |
| 11 May 2023 | GRANT_AWARD | PROS Holdings, Inc. | 7,205 | 0.00 USD | deriv |
| 15 Feb 2023 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 20,182 | 0.00 USD | deriv |
| 04 Nov 2022 | SALE | PROS Holdings, Inc. | 6,000 | 25.76 USD | |
| 17 May 2022 | PURCHASE | PLUS THERAPEUTICS, INC. | 30,000 | 0.55 USD | |
| 13 May 2022 | SALE | PROS Holdings, Inc. | 1,536 | 24.91 USD | |
| 12 May 2022 | EXERCISE | PROS Holdings, Inc. | 4,388 | 24.23 USD | |
| 12 May 2022 | GRANT_AWARD | PROS Holdings, Inc. | 6,809 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 11 Sept 2023.